Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Discover how to make zero based budget adjustments in response to changes in income. Maintain your financial stability today.
23,257 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Los Angeles Unified School District placed its superintendent on paid leave as federal investigators scrutinize a pas...
Memory-chip stocks, led by Micron, fell as near-term demand remained uneven. Analysts warn fundamentals stay solid, w...
Bitcoin surges past $71,000 as South Korea's stock market suffers a sweeping rout, signaling a potential decoupling i...
Dogecoin has jumped sharply in a single session, reviving questions about whether a broader bull market is reloading....
Berkshire Hathaway has resumed stock buybacks, purchasing $15 million of its own shares. CEO Greg Abel personally bou...
A Danish study ties heavy chatbot use to worsening mental health symptoms among patients with psychosis, raising conc...
Lucid delivered higher volumes and nudged toward improving efficiency, signaling a potential turn in its long EV jour...
Markets staged a broad reversal as crude collapsed and investors priced in a potential de-escalation in a tense geopo...
Alphabet stands at a crossroads: Sundar Pichai could pull in up to $692 million over three years, but half of that de...
As markets navigate 2026, investors cling to long-term tech exposure. A fresh look at VGT argues it can anchor retire...
Propy has acquired Boss Law's Florida title division, extending its AI-driven closing platform to St. Petersburg and ...